[29] The brand new century also ushered inside a broader change in political attitude towards psychedelic drugs—exclusively throughout the Food and Drug Administration. Curtis Wright, then deputy director with the FDA Division of Anesthetic, Essential Treatment and Addiction Prescription drugs explained a commitment for this transformation: "the